Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
Aug 03, 2022: Advanced Proteome Therapeutics receives issued patent
Apr 13, 2022: Advanced Proteome Therapeutics receives notice of allowance for patent claims
Feb 03, 2022: Advanced Proteome Therapeutics update on plans for 2022
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Advanced Proteome Therapeutics Corporation (APC) focuses on the development of anticancer technologies which capitalize on the properties of a natural human antibody. The company is advancing a site-specific protein modification technology platform that directly targets cancerous tumors while avoiding the destruction of normal cells. It also provides Universal Antibody Connectors (UAC), a site-selective labeling technology platform that enables the production of homogenous ADC candidates. APC works in collaboration with several academic and industrial institutions to advance the proof of concept studies of its discovery stage ARCs product pipeline and ADC candidates. APC is headquartered in Boston, Massachusetts, the US.Advanced Proteome Therapeutics Corp Key Recent Developments
Nov 21, 2022: Advanced Proteome Therapeutics Announces Appointment of Mr. Cory Brandolini to the Board of DirectorsAug 03, 2022: Advanced Proteome Therapeutics receives issued patent
Apr 13, 2022: Advanced Proteome Therapeutics receives notice of allowance for patent claims
Feb 03, 2022: Advanced Proteome Therapeutics update on plans for 2022
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company- Advanced Proteome Therapeutics Corp - Key Facts
- Advanced Proteome Therapeutics Corp - Key Employees
- Advanced Proteome Therapeutics Corp - Key Employee Biographies
- Advanced Proteome Therapeutics Corp - Major Products and Services
- Advanced Proteome Therapeutics Corp - History
- Advanced Proteome Therapeutics Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- Advanced Proteome Therapeutics Corp - Business Description
- R&D Overview
- Advanced Proteome Therapeutics Corp - SWOT Analysis
- SWOT Analysis - Overview
- Advanced Proteome Therapeutics Corp - Strengths
- Advanced Proteome Therapeutics Corp - Weaknesses
- Advanced Proteome Therapeutics Corp - Opportunities
- Advanced Proteome Therapeutics Corp - Threats
- Advanced Proteome Therapeutics Corp - Key Competitors
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- Advanced Proteome Therapeutics Corp, Recent Deals Summary
- Nov 21, 2022: Advanced Proteome Therapeutics Announces Appointment of Mr. Cory Brandolini to the Board of Directors
- Aug 03, 2022: Advanced Proteome Therapeutics receives issued patent
- Apr 13, 2022: Advanced Proteome Therapeutics receives notice of allowance for patent claims
- Feb 03, 2022: Advanced Proteome Therapeutics update on plans for 2022
- Methodology
- Ratio Definitions
- About the Publisher
- Contact the Publisher
- Disclaimer
- Advanced Proteome Therapeutics Corp, Key Facts
- Advanced Proteome Therapeutics Corp, Key Employees
- Advanced Proteome Therapeutics Corp, Key Employee Biographies
- Advanced Proteome Therapeutics Corp, Major Products and Services
- Advanced Proteome Therapeutics Corp, History
- Advanced Proteome Therapeutics Corp, Other Locations
- Advanced Proteome Therapeutics Corp, Subsidiaries
- Advanced Proteome Therapeutics Corp, Key Competitors
- Advanced Proteome Therapeutics Corp, Ratios based on current share price
- Advanced Proteome Therapeutics Corp, Annual Ratios
- Advanced Proteome Therapeutics Corp, Interim Ratios
- Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- Advanced Proteome Therapeutics Corp, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- Advanced Proteome Therapeutics Corp, Performance Chart (2017 - 2021)
- Advanced Proteome Therapeutics Corp, Ratio Charts
- Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Oncolinx LLC
- Alaunos Therapeutics Inc
- Aileron Therapeutics Inc
- Oncorus Inc
- BioNTech US Inc
- Surface Oncology Inc
